REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.
Tamaki A, Kato T, Sakurai Y, Sato K, Adachi K, Tadehara M, Kogami T, Matsushita M, Hoshino A, Sanoyama I, Numata Y, Umezawa A, Ichinoe M, Ichihara M, Kusano C, Murakumo Y.
Tamaki A, et al. Among authors: murakumo y.
Cancer Sci. 2024 Feb;115(2):660-671. doi: 10.1111/cas.16044. Epub 2023 Dec 21.
Cancer Sci. 2024.
PMID: 38130032
Free PMC article.